Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice

Neuroscience Letters

Volumn 204, Issue 1-2, 1996, Pages 85-88

  Hassouna, Imam ^a,b   Wickert, Hannes ^a   Zimmermann, Manfred ^a   Gillardon, Frank ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Menoufia University   (Egypt)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Bax; Neurodegeneration; Parkinson's disease; Programmed cell death; Substantia nigra

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; MESSENGER RNA; PROTEIN BAX; 1 METHYL 4 PHENYLPYRIDINIUM; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBSTANTIA NIGRA; ANIMAL; C57BL MOUSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; PROTO ONCOGENE; RAT; UPREGULATION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; DOPAMINE AGENTS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; PROTO-ONCOGENES; RATS; SUBSTANTIA NIGRA; UP-REGULATION;

EID: 0029670980     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12323-5     Document Type: Article

References (26)

1. Bandy, B. and Davison, A.J., Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?, Free Radical Biol. Med., 8 (1990) 523-539.
2. Burns, R.S., Chiueh, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M. and Kopin, I.J., A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Proc. Natl. Acad. Sci. USA, 80 (1983) 4546-4550.
3. +, Free Radical Biol. Med., 13 (1992) 581-583.
4. Dipasquale, B., Marini, M. and Youle, R.J., Apoptosis and DNA degradation by 1-methyl-4-phenylpyridinium in neurons, Biochem. Biophys. Res. Commun., 181 (1991) 1442-1448.
5. Duchemin, A.M., Gudehithlu, K.P., Neff, N.H. and Hadjiconstantinou, M., c-fos mRNA in mouse brain after MPTP treatment, Neurochem. Int., 20 (1992) 281-287.
6. Gillardon, F., Wickert, H. and Zimmermann, M., Differential expression of bcl-2 and bax mRNA in axotomized dorsal root ganglia of young and adult rats, Eur. J. Neurosci., 6 (1994) 1641-1644.
7. Gillardon, F., Wickert, H. and Zimmermann, M., Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain, Neurosci. Lett., 192 (1995) 85-88.
8. +) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles, Biochem. Biophys. Res. Commun., 170 (1990) 1049-1055.
9. Hockenbery, D., Oltvai, Z., Yin, X-M., Milliman, C. and Korsmeyer, S.J., Bcl-2 functions in an antioxidant pathway apoptosis, Cell. 75 (1993) 241-251.
10. 28k-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity, Mol. Brain Res., 13 (1992) 251-261.
11. +)-induced cell death in PC12 cells: inhibitory effects of several drugs, Neurochem. Int., 25 (1994) 419-424.
12. Kidata, S., Miyashita, T., Tanaka, S. and Reed, J.C., Investigations of antisense oligonucleotides targeted against bcl-2 RNAs, Antisense Res. Dev., 3 (1993) 157-169.
13. Krajewski, S., Krajewska, M., Shabaik, A., Miyashita, T., Wang, H.G. and Reed, J.C., Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2, Am. J. Pathol., 145 (1994) 1323-1336.
14. +): identification of a metabolite of MPTP, a toxin selective to the substantia nigra, Neurosci. Lett., 48 (1984) 87-92.
15. +) in ventral mesencephalic-striatal co-culture in rat, Neurosci. Lett., 170 (1994) 191-194.
16. Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell, 74 (1993) 609-619.
17. Przedborski, S., Kostic, V., Jackson-Lewis, V., Naini, A.B., Simonetti, S., Fahn, S., Carlson, E., Epstein, C. and Cadet, J.L., Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity, J. Neurosci., 12 (1992) 1658-1667.
18. Reed, J.C., Bcl-2 and the regulation of programmed cell death, J. Cell. Biol., 124 (1994) 1-6.
19. Sambrook, J., Fritsch, E.F. and Maniatis, T., Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
20. Schotcher, K.P., Irwin, I., DeLanney, L.E., Lagston, J.W. and Di Monte, D., Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes, J. Neurochem., 54 (1990) 1295-1301.
21. Schulz, J.B., Matthews, R.T., Muqit, M.K., Browne, S.E. and Flint Beal, M., Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice, J. Neurochem., 64 (1995) 936-939.
22. Thompson, C.B., Apoptosis in the pathogenesis and treatment of diseases, Science, 267 (1995) 1456-1462.
23. Tilly, J.L., Tilly, K.I., Kenton, M.L. and Johnson, A.L., Expression of members of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xl messenger ribonucleic acid levels, Endocrinology, 136 (1995) 232-241.
24. Veis, D.J., Sorenson, C.M., Shutter, J.R. and Korsmeyer, S.J., Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair, Cell, 75 (1993) 229-240.
25. Yin, X.M., Oltvai, Z.N. and Korsmeyer, S.J., BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax, Nature, 369 (1994) 321-323.
26. Zang, L.-Y. and Misra, H.P., Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, J. Biol. Chem., 268 (1993) 16504-16512.